Acral Lentiginous Melanoma - Misdiagnosis, eferral delay and 5 years specific survival according to site

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 14, 2014, Pages 1990-1996

  Boriani, F ^a   O'Leary, F ^a   Tohill, M ^a   Orlando, A ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

Acral lentiginous melanoma; Cutaneous malignant melanoma; Melanoma; Skin cancer

Indexed keywords

ACRAL LENTIGINOUS MELANOMA; ADVANCED CANCER; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; DIAGNOSTIC ERROR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PATIENT REFERRAL; RELIABILITY; SURVIVAL RATE; ADULT; AGED; COHORT ANALYSIS; LONGITUDINAL STUDY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SKIN NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIAGNOSTIC ERRORS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84940244128     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. REED RJ. ACRAL LENTIGINOUS MELANOMA. IN: HARTMANN W, KAY S, REED RJ, EDS. New concepts in surgical pathology of the skin. New York: John Wiley & Sons, Inc, 1976; 89-90.
2. HUTCHINSON J. Melanosis often not black: melanotic whitlow. Br Med J 1886; 1: 491-494.
3. SHAW JH, KOEA JB. Acral (volar-subungual) melanoma in Aukland, new Zealand. Br J Surg 1988; 75: 69-72.
4. CASCINELLI N, ZURIDDA S, GALIMBERTI V, BARTOLI, C, BUFALINO R, DEL PRATO I, MASCHERONI L, TESTORI A, CLEMENTE C. Acral lentiginous melanoma. A histological type without prognostic significance. J Dermatol Surg Oncol 1994; 20: 817-22.
5. RIDGEWAY CA, HIEKEN TJ, RONAN SG, KIM DK, DAS GUPTA TK. Acral lentiginous melanoma. Arch Surg 1995; 130: 88-92.
6. RICHARD MA, GROB JJ, AVRIL MF, DELAUNAY M, GOUVERNET J, WOLKENSTEIN P, SOUTEYRAND P, DRENO B, BONERANDI JJ, DALAC S, MACHET L, GUILLAUME JC, CHEVRANT-BRETON J. VILMER C, AUBIN F, GUILLOT B, BEYLOT-BARRY M, LOK C, RAISON-PEYRON N, CHEMALY P. Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer 2000; 89: 271-279.]
7. PALADUGU RR, WINBERG CD, YONEMOTO RH. Acral lentiginous melanoma. A clinicopathologic study of 36 patients. Cancer 1983; 52: 161-168.
8. CRESS RD, HOLLY EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians and blacks: ana analysis of California cancer registry data, 1988-93. Cancer Causes Control 1997; 8: 246-252.
9. CHANG JW, YEH KY, WANG CH, YANG TS, CHIANG HF, WEI FC, KUO TT, YANG CH AL. Malignant melanoma in Taiwan: a prognostic study of 181 cases. Melanoma Res 2004; 14: 537-541.
10. HUDSON DA, KRIGE JE. Melanoma in black South Africans. J Am Coll Surg 1995; 180: 65-71.
11. SLINGLUFF CL JR, VOLLMER R, SEIGLER HF. Acral melanoma: a review of 185 patients with identification of prognostic variables. J Surg Oncol 1990; 45: 91-98.
12. BISHOP JA, CORRIE PG, EVANS J, GORE ME, HALL PN, KIRKHAM N, ROBERTS DL, ANSTEY AV, BARLOW RJ, COX NH; MELANOMA STUDY GROUP; BRITISH ASSOCIATION OF DERMATOLOGISTS. UK guidelines for the management of cutaneous melanoma. Br J Plast Surg 2002; 55: 46-54.
13. MARSDEN JR, NEWTON-BISHOP JA, BURROWS L, COOK M, CORRIE PG, COX NH, GORE ME, LORIGAN P, MACKIE R, NATHAN P, PEACH H, POWELL B, WALKER C; BRITISH ASSOCIATION OF DERMATOLOGISTS (BAD) CLINICAL STANDARDS UNIt. Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg 2010; 63: 1401-1419.
14. FEIBLEMAN CE, STOLL H, MAIZE JC. Melanomas of the palm, sole and nailbed.Cancer 1980; 46: 2492-2504.
15. BENNETT DR, WASSON D, MACARTHUR JD. The effect of misdiagnosis and delay indiagnosis on clinical outcome in melanomas of the foot. J Am Coll Surg 1994; 179: 279-284.
16. ALBRESKI D, BRETT SLOAN S. Melanoma of the feet: misdiagnosed and misunderstood. Clin Dermatol 2009; 27: 556-563.
17. TALLEY, LI, SOONG S, HARRISON RA, MCCARTHY WH, URIST MM, BALCH CM. Clinical outcomes of localized melanoma of the foot: a case-control study. J Clin Epidemiol 1998; 10: 853-857.
18. BASTIAN BC, KASHANI-SABET MK, HAMM H, GODFREY T, MOORE DH 2ND, BRÖCKER EB, LEBOIT PE, PINKEL D. Gene amplifications characterize acral melanoma and permit the detection of occult tumour cells in the surrounding skin. Cancer Res 2000; 60: 1968-1973.
19. BRADFORD PT, GOLDSTEIN AM, MCMASTER ML, TUCKER MA. Acral lentiginous melanoma. Incidence and survival pattern in the United States, 1986-2005. Arch Dermatol 2009; 145: 427-434.
20. SOUDRY E, GUTMAN H, FEINMESSER M, GUTMAN R, SCHACHTER J. "Gloves-and-socks" melanoma: does histology make a difference? Dermatol Surg 2008; 34: 1372-1378.
21. REX J, PARADELO C, MANGAS C, HILARI JM, FERNÁNDEZFIGUERAS MT, FERRÁNDIZ C. Management of primary cutaneous melanoma of the hands and feet: a clinicoprognostic study. Dermatol Surg 2009; 35: 1505-1503.
22. COLEMAN WP, PHILIP RL, REED RR, KREMENTZ ET. Acral lentiginous melanoma. Arch Dermatol 1980: 116: 773-776.
23. KREMENTZ ET, REED RJ, COLEMAN WP III. Acral lentiginous melanoma. A clinicopathologic entity. Ann Surg 1982; 195: 632-635.
24. BREUNINGER H, KÖHLER C, DREPPER H, BASTIAN B, BRÖCKER EB, GÖHL J, GROTH W, HERMANEK P, HOHENBERGER W, LIPPOLD AL. [Is acrolentiginous melanoma (ALM) more malignant than superficially spreading melanoma (SSM) at a high-risk site? A matched-pair comparison between 113 ALM and SSM within the scope of a multicenter study] Hautarzt 1994; 45: 529-531.
25. MCGOVERN VJ. The nature of melanoma. A critical review. J Cutan Pathol 1982; 9: 61-81.
26. PHAN A, TOUZET S, DALLE S, RONGER-SAVLÉ S, BALME B, THOMAS L. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. Br J Dermatol 2006; 155: 561-569.
27. SONDERGAARD K, OLSEN G. Malignant melanoma of the foot. A clinicopathological study of 125 primary cutaneous malignant melanomas. Acta Path Microbiol Immunol Scand A 1980; 88: 275-283.